Clinical Trials Directory

Trials / Unknown

UnknownNCT06194253

Reasons for Recourse and Diagnoses Associated With Early Recourse to an Emergency Structure After Initial Treatment

Evaluation of the Reasons for Recourse and Diagnoses Associated With Early Recourse to an Emergency Structure After Initial Treatment Followed by a Return Home

Status
Unknown
Phase
Study type
Observational
Enrollment
500,000 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

To date, studies have been carried out on emergency department revisits but most are studies carried out in Anglo-Saxon territories. The studies carried out in France, for their part, concern the elderly geriatric population, or populations with specific pathologies such as child psychiatrists or patients with acute heart failure, but not the general adult population. Nevertheless, these studies have shown that knowledge of the risk factors for early readmission of a patient makes it possible to carry out targeted prevention actions in order to reduce this early recourse rate. However, in a context of increasing emergency flow and increasing tension in the field with limited healthcare resources, returning home and outpatient care are increasingly favored. However, these strategies only make sense if outpatient follow-up is organized when early reconsultation is possible for certain indications that remain to be determined. In this context, it would be interesting to have information on the reasons for which patients return to the emergency room early after initial treatment. This would indeed make it possible to consider carrying out preventive actions in the long term in order to reduce this revisit rate on the one hand and on the other hand to identify the signs of seriousness which should bring the patient back to the emergency room as soon as possible.

Conditions

Timeline

Start date
2023-07-10
Primary completion
2025-07-01
Completion
2025-07-01
First posted
2024-01-08
Last updated
2024-01-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06194253. Inclusion in this directory is not an endorsement.